scispace - formally typeset
K

Kirti Kaul

Researcher at Ohio State University

Publications -  32
Citations -  1924

Kirti Kaul is an academic researcher from Ohio State University. The author has contributed to research in topics: Diabetes mellitus & Insulin resistance. The author has an hindex of 13, co-authored 27 publications receiving 1401 citations. Previous affiliations of Kirti Kaul include University of Düsseldorf & The Ohio State University Wexner Medical Center.

Papers
More filters
Journal ArticleDOI

Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis

TL;DR: Adaptation of the liver ("hepatic mitochondrial flexibility") at early stages of obesity-related insulin resistance, which is subsequently lost in NASH is suggested.
Journal ArticleDOI

Pathophysiology of Diabetic Retinopathy

TL;DR: The aim of this paper is to introduce the multiple interconnecting biochemical pathways that have been proposed and tested as key contributors in the development of diabetic retinopathy, namely, increased polyol pathway, activation of protein kinase C (PKC), increased expression of growth factors such as vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1).
Book ChapterDOI

Introduction to diabetes mellitus.

TL;DR: The types of diabetes and diabetic complications such as impairment of immune system, periodontal disease, retinopathy, nephropathy, somatic and autonomic neuropathy, cardiovascular diseases and diabetic foot are introduced.
Journal ArticleDOI

Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?

TL;DR: Evidence showing a link between circulating and locally produced inflammatory biomarkers, such as cell adhesion molecules, pro-inflammatory cytokines and tumour necrosis factor-alpha, TNF-α with the development and progression of diabetic micro-vascular complications is summarized.
Journal ArticleDOI

Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver

TL;DR: Hepatic insulin resistance originates from lipotoxicity but not from lower mitochondrial capacity, which can even transiently adapt to increased peripheral lipolysis, which is prevented during increased hepatic lipogenesis only if adipose tissue lipid storage capacity is preserved.